Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like Mithra Pharmaceuticals Launches A Capital Increase By Means Of A Private Placement Via An Accelerated Bookbuild Offering June 20, 2017 BrainStorm Cell Names And To Its Board Of Directors As Company Prepares For Clinical And Commercial Success February 26, 2017 Oregon Bioscience Association Release: Oregon???s Life Science Industry On Display: Oregon Bioscience Showcase 2017 September 20, 2017
Mithra Pharmaceuticals Launches A Capital Increase By Means Of A Private Placement Via An Accelerated Bookbuild Offering June 20, 2017
BrainStorm Cell Names And To Its Board Of Directors As Company Prepares For Clinical And Commercial Success February 26, 2017
Oregon Bioscience Association Release: Oregon???s Life Science Industry On Display: Oregon Bioscience Showcase 2017 September 20, 2017
